MAR 25, 202662 MINS READ
Crosslinked polyglycolic acid is fundamentally derived from the ring-opening polymerization of glycolide, yielding linear PGA chains with repeating glycolic acid units (-OCH₂CO-). The crosslinking process introduces covalent or ionic bridges between these chains, creating a three-dimensional network. The molecular weight of the precursor PGA typically ranges from 100,000 to 1,000,000 Da (mass average molecular weight, Mw), with polydispersity indices (Mw/Mn) between 1.5 and 4.0, ensuring sufficient chain length for effective entanglement and crosslinking 5. The melting point of high-purity PGA lies between 197°C and 245°C, while the melt crystallization temperature (Tc2) ranges from 130°C to 195°C, reflecting the semi-crystalline nature of the polymer 511.
Crosslinking modifies the polymer's thermal and mechanical behavior by restricting chain mobility. For instance, the introduction of ester-based crosslinks (e.g., via polyethylene glycol diacrylate) or hydrazone bonds (via adipic acid dihydrazide with oxidized alginate-PGA blends) alters the glass transition temperature (Tg) and reduces the degree of crystallinity 6. The molecular weight between crosslinks (Mc) is a critical parameter: lower Mc values (achieved through higher crosslinker concentrations) yield stiffer, more brittle networks, while higher Mc values produce elastomeric materials with greater flexibility 6. Differential scanning calorimetry (DSC) studies reveal that crosslinked PGA exhibits a temperature-lowering crystallization peak (Tc) that is 3–18°C lower than that of uncrosslinked PGA when blended with polylactic acid (PLA) at 5–30 mass%, indicating disrupted crystallization kinetics due to crosslink-induced constraints 5.
The chemical structure of crosslinked PGA can incorporate diverse functional groups depending on the crosslinking agent. For example, crosslinking with N-protected amino acids via polyethylene glycol spacers introduces amide linkages, enhancing hydrolytic stability 6. Alternatively, photoreactive crosslinking using UV-activated agents generates carbon-carbon bonds, offering rapid gelation and spatial control 6. The choice of crosslinking chemistry directly impacts the degradation mechanism: ester bonds hydrolyze relatively quickly under physiological conditions (pH 7.4, 37°C), while amide bonds degrade more slowly, and hydrazone bonds exhibit intermediate lability 6.
Chemical crosslinking is the most widely adopted method for producing crosslinked PGA, leveraging bifunctional or multifunctional reagents to form covalent bridges between polymer chains. Polyethylene glycol (PEG)-based crosslinkers are particularly prevalent due to their biocompatibility and tunable molecular weight. For instance, PEG derivatives with electrophilic leaving groups (e.g., succinimidyl esters, mesylates, tosylates) react with hydroxyl or carboxyl groups on PGA chains under mild conditions (pH 7.0–8.0, 37°C) 14. The concentration of the crosslinking agent critically determines network density: optimal ranges of 0.3–3 mM yield homogeneous gels with controlled pore sizes, whereas higher concentrations risk premature gelation and inhomogeneity 14.
Cyclic carboxylic polyanhydrides represent an emerging class of crosslinkers that accelerate the crosslinking process. When combined with sulfonic acid catalysts, these agents reduce reaction times from hours to minutes and lower reaction temperatures from 150–200°C to 80–120°C, preserving the integrity of thermally sensitive additives such as growth factors or drugs 16. The resulting crosslinked polyesters exhibit enhanced degradability in phosphate-buffered saline (PBS) at 37.5°C, with mass loss rates of 20–25% after 3 hours at 120°C, compared to 10–15% for conventionally crosslinked PGA 716.
Adipic acid dihydrazide (AAD) is another effective crosslinker, particularly for oxidized PGA (polyaldehyde PGA). Oxidation of PGA introduces aldehyde groups along the backbone, which react with the hydrazide groups of AAD to form hydrazone linkages 6. This approach enables two-stage gelation: rapid ionic crosslinking (via calcium ions) provides immediate viscosity for injectability, followed by slower covalent crosslinking (over hours) to achieve mechanical rigidity 6. The hydrazone bond's pH-sensitive hydrolysis (accelerated under acidic conditions) offers programmable degradation for drug release applications.
Irradiation-based crosslinking employs gamma rays, electron beams, or UV light to generate free radicals on PGA chains, which subsequently recombine to form covalent crosslinks. This method is particularly advantageous for polysaccharide-PGA blends, such as agarose-PGA composites, where the gel state during irradiation ensures uniform crosslink distribution 4. Gamma irradiation at doses of 10–50 kGy induces crosslinking without requiring chemical additives, thereby avoiding residual toxicity concerns 4. However, excessive irradiation (>100 kGy) can cause chain scission, reducing molecular weight and compromising mechanical properties.
UV-activated crosslinking using photoreactive agents (e.g., benzophenone derivatives) offers spatial and temporal control, enabling in situ gelation during surgical procedures 6. The reaction is initiated by UV exposure (wavelength 320–400 nm) for 30–120 seconds, producing crosslinked networks with elastic moduli ranging from 0.1 to 2.0 GPa, depending on the photoreactive agent concentration and exposure time 6.
Hybrid systems combine chemical and physical crosslinking to optimize mechanical properties and degradation kinetics. For example, PGA can be first ionically crosslinked with divalent cations (e.g., Ca²⁺, Mg²⁺) to form a weak gel, followed by covalent crosslinking with PEG-diacrylate to reinforce the network 6. This dual-crosslinking strategy is particularly useful for injectable scaffolds in tissue engineering, where initial ionic gelation provides shape retention, and subsequent covalent crosslinking ensures long-term stability.
The elastic modulus of crosslinked PGA varies widely depending on the crosslink density and the molecular weight between crosslinks (Mc). Lightly crosslinked PGA (Mc > 10,000 Da) exhibits elastomeric behavior with moduli in the range of 0.1–0.5 GPa, suitable for soft tissue applications such as wound dressings or vascular grafts 8. In contrast, highly crosslinked PGA (Mc < 5,000 Da) achieves moduli of 1.5–2.0 GPa, approaching the stiffness of cortical bone, making it ideal for load-bearing orthopedic implants such as screws, pins, and plates 810.
Tensile strength is similarly influenced by crosslink density. Uncrosslinked PGA typically exhibits tensile strengths of 60–100 MPa, whereas crosslinked PGA can reach 120–180 MPa, depending on the crosslinking method and degree 8. For instance, PGA crosslinked with lysine (forming amide bonds) demonstrates tensile strengths of 150 MPa and elongation at break of 15–20%, balancing strength and ductility 6. Dynamic mechanical analysis (DMA) reveals that the storage modulus (E') of crosslinked PGA increases by 30–50% compared to linear PGA at physiological temperatures (37°C), reflecting enhanced dimensional stability 5.
Crosslinking significantly modulates the degradation rate of PGA by restricting water penetration and limiting ester bond accessibility. Linear PGA degrades completely within 2–4 weeks in PBS (pH 7.4, 37°C), whereas crosslinked PGA can extend this period to 8–16 weeks, depending on the crosslink density and chemistry 8. Thermogravimetric analysis (TGA) indicates that crosslinked PGA retains 80–90% of its mass after 3 hours at 120°C in water, compared to 60–70% for uncrosslinked PGA 7.
The degradation mechanism involves hydrolytic cleavage of ester bonds, producing glycolic acid as the primary degradation product. Glycolic acid is metabolized via the Krebs cycle, ensuring biocompatibility 8. However, the local accumulation of acidic degradation products can lower pH to 4–5, potentially causing inflammation. Crosslinking with pH-buffering agents (e.g., calcium carbonate) or incorporating basic comonomers (e.g., poly-ε-caprolactone) mitigates this issue 5.
Crosslinked PGA exhibits superior barrier properties against gases (O₂, CO₂) and water vapor compared to linear PGA, attributed to the reduced free volume and restricted chain mobility in the crosslinked network 5. Gas permeability coefficients for crosslinked PGA range from 0.5 to 2.0 × 10⁻¹⁸ cm³·cm/(cm²·s·Pa), making it suitable for packaging applications requiring high barrier performance 5. The addition of inorganic fillers (e.g., talc, calcium carbonate) at 10–70 mass% further enhances barrier properties by creating tortuous diffusion paths, reducing permeability by 40–60% 7.
Melt-kneading is a scalable method for producing crosslinked PGA composites, particularly when incorporating inorganic fillers or blending with other polymers. The process involves heating PGA to 230–270°C in a twin-screw extruder, adding the crosslinking agent (e.g., PEG-diacrylate) and fillers, and kneading for 5–15 minutes under nitrogen atmosphere to prevent oxidative degradation 57. The residence time and screw speed are optimized to achieve uniform dispersion of the crosslinker and fillers while minimizing thermal degradation. The extruded material is then pelletized and subjected to post-crosslinking via heat treatment (150–180°C for 2–6 hours) or irradiation (10–30 kGy gamma dose) 7.
For PGA-PLA blends, melt-kneading at 240–260°C with 5–30 mass% PLA yields resin compositions with Tc values 3–18°C lower than pure PGA, improving moldability and reducing warpage during injection molding 5. The deflection temperature under load (DTUL) of these blends exceeds 120°C, ensuring dimensional stability in high-temperature applications 7.
Solution casting is preferred for fabricating thin films or membranes of crosslinked PGA. PGA is dissolved in aprotic polar solvents such as hexafluoroisopropanol (HFIP) or 1,1,1,3,3,3-hexafluoro-2-propanol at concentrations of 5–15 wt%, and the crosslinking agent is added at molar ratios of 1:10 to 1:50 (crosslinker:PGA repeat units) 11. The solution is cast onto a substrate (e.g., glass, Teflon) and dried at 40–60°C under vacuum for 12–24 hours to remove the solvent. Crosslinking is then initiated by UV irradiation (for photoreactive agents) or thermal treatment (for thermally activated agents) 11.
To minimize residual solvent, which can compromise biocompatibility, the films are subjected to supercritical CO₂ extraction or prolonged vacuum drying (10⁻² mbar, 80°C, 48 hours) 11. The resulting films exhibit thicknesses of 50–500 μm, with tensile strengths of 80–120 MPa and elongation at break of 10–25% 11.
In situ gelation involves mixing PGA precursors with crosslinking agents immediately before injection, allowing gelation to occur within the target tissue. This approach is particularly useful for minimally invasive procedures. For example, oxidized PGA (with aldehyde groups) is mixed with AAD in PBS at pH 7.4, and the mixture is injected via a syringe 6. Ionic crosslinking with Ca²⁺ (added at 10–50 mM) provides immediate viscosity (10³–10⁴ Pa·s), preventing extravasation, while covalent hydrazone bond formation (over 2–6 hours) solidifies the scaffold 6. The gelation time is tunable by adjusting the AAD concentration (0.5–5 mM) and temperature (25–37°C).
Crosslinked PGA scaffolds are extensively used in tissue engineering due to their biodegradability, biocompatibility, and tunable mechanical properties. In cartilage repair, PGA-glycosaminoglycan (GAG) crosslinked complexes mimic the extracellular matrix (ECM) composition, providing a conducive environment for chondrocyte proliferation and differentiation 14. These scaffolds are synthesized by crosslinking chondroitin sulfate or hyaluronic acid with polycations (e.g., poly-L-lysine) using PEG-based crosslinkers (0.3–3 mM) under physiological conditions 14. The resulting hydrogels exhibit compressive moduli of 50–200 kPa, matching the mechanical properties of native cartilage, and support cell viability exceeding 90% after 7 days of culture 14.
For bone regeneration, crosslinked PGA composites reinforced with hydroxyapatite (HA) or tricalcium phosphate (TCP) at 30–70 mass% achieve compressive strengths of 80–150 MPa, suitable for non-load-bearing applications such as craniofacial reconstruction 7. The inorganic fillers also buffer acidic degradation products, maintaining pH above 6.5 and reducing inflammatory responses 7. In vivo studies in rabbit femoral defect models demonstrate complete bone ingrowth within 12–16 weeks, with scaffold degradation synchronized with new tissue formation 7.
Crosslinked PGA meshes and felts are employed as wound dressings for burns, traumatic injuries, and surgical incisions 8. These materials protect the wound surface, absorb exudate, and gradually degrade as the tissue heals, eliminating the need for removal 8. The porous structure (pore sizes 50–200 μm) facilitates cell infiltration and vascularization, accelerating healing by 20–30% compared to conventional dressings 8.
Crosslinked PGA matrices serve as carriers for sustained drug release, leveraging their biodegradability to achieve zero-order release kinetics. Hydrophobic drugs (e.g., paclitaxel, doxorubicin) are encapsulated within crosslinked PGA microspheres (diameter 10–100 μm) via emulsion solvent evaporation 11. The crosslink density controls the release rate: lightly crosslinked microspheres (Mc > 8,000 Da) release 80% of
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| KUREHA CORPORATION | High-barrier packaging materials and drilling downhole tools requiring dimensional stability at elevated temperatures and controlled degradation in aqueous environments. | PGA Resin Composition for Packaging | Achieved 20-25% mass loss after 3 hours at 120°C in water with deflection temperature under load exceeding 120°C through melt-kneading with 10-70 mass% inorganic fillers, providing enhanced barrier properties and thermal stability. |
| AMERICAN CYANAMID COMPANY | Surgical reinforcing devices including pins, screws, plates, wound dressings for burns and traumatic injuries, and absorbable gauze/felt materials that protect wound surfaces and eliminate removal procedures. | PGA Prosthetic Devices | Biodegradable and bioabsorbable polyglycolic acid with surgically useful mechanical properties (tensile strength 60-100 MPa) that is completely absorbed and replaced by living tissue within 2-4 weeks. |
| TERUMO KABUSHIKI KAISHA | Medical treatment materials for tissue adhesion and sealing applications requiring biocompatibility, biodegradability, and strong bonding without infection risk from non-living organism sources. | Crosslinkable Polysaccharide Medical Material | Forms crosslinked products through covalent bonding with active ester groups reactive with active hydrogen-containing groups upon contact with alkaline water, achieving high bond strength with low toxicity and biodegradability. |
| JAPAN SCIENCE AND TECHNOLOGY AGENCY | Tissue regeneration matrices for cartilage repair and extracellular matrix scaffolds where cells can be mixed during crosslinking reaction for enhanced tissue engineering applications. | GAG-Polycation Crosslinked Complex | Homogeneous crosslinking of glycosaminoglycan and polycation using polyethylene glycol-based crosslinkers (0.3-3 mM) under physiological conditions (pH 7.0-8.0, 37°C), enabling cell encapsulation with compressive moduli of 50-200 kPa. |
| COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN | Medical biomaterials and drug delivery systems requiring preservation of thermally sensitive active pharmaceutical ingredients during crosslinking process with controlled biodegradation profiles. | Crosslinked Glycerol Polyester System | Accelerated crosslinking using cyclic carboxylic polyanhydride with sulfonic acid catalyst, reducing reaction time from hours to minutes and temperature from 150-200°C to 80-120°C while maintaining degradability in PBS at 37.5°C. |